Current Status of Surrogates for Survival in Cancer Trials
Publié le
IDDI organized a webinar on the Current Status of Surrogates for Survival in Cancer Trials. VIEW THE RECORDING OF THE…
Personalized Cancer Medicine Needs Randomized Trials
Publié le
IDDI organized a webinar on Personalized Cancer Medicine Needs Randomized Trials. Clinical cancer research is undergoing profound changes, mostly because…
From Biomarkers to In-vitro Companion Diagnostic Device
Publié le
IDDI organized a webinar on the analytical validation of in-vitro diagnostic devices entitled ‘From Biomarkers to In-vitro Companion Diagnostic Device :…
Future of Cancer Clinical Trials
Publié le
IDDI organized a webinar on the Future of Cancer Clinical Trials. Cancer clinical trials have been a major determinant of…
Implementing Adaptive Trials: Operational Considerations
Publié le
IDDI organized a webinar on Implementing Adaptive Trials: Operational Considerations. WATCH RECORDED WEBINAR TO ACCESS THE PRESENTATION OF THIS ON-DEMAND WEBINAR,…
Pros and Cons of Adaptive Designs
Publié le
IDDI organized a webinar on Pros and Cons of Adaptive Designs. Topics included: Continual reassessment methods for phase I trials Adaptive…
Efficient Designs in Phase I Trials in Oncology
Publié le
IDDI organized a webinar on Efficient Designs in Phase I oncology trials. The key learning objectives of this webinar were…
Fruitful Sponsor/CRO Collaboration: How to Succeed
Publié le
Efficient CRO Collaboration IDDI organized a webinar on FRUITFUL SPONSOR/CRO COLLABORATION: HOW TO SUCCEED. The goal of this talk is…
The Need for Better Endpoints: Towards a More Efficient Drug Development in Oncology
Publié le
IDDI organized a webinar on THE NEED FOR BETTER CLINICAL ENDPOINTS : TOWARDS A MORE EFFICIENT DRUG DEVELOPMENT IN ONCOLOGY The…
Central Statistical Monitoring of Clinical Trials
Publié le
IDDI organized a webinar on Statistical Approach to Central Monitoring of Clinical Trials This webinar presented the underlying principles of a…